CardioSert (Novel Patent-Protected Technology) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
CardioSert (Novel Patent-Protected Technology) General Information
Description
Provider of patented guide wire technology services in Israel. The company's technology services include steering and adjustable stiffness to guide wires used in interventional cardiology, radiology and vascular surgery, enabling physicians with the ability to control the tip curvature, to adjust tip stiffness in a gradually continuous manner, and to produce impacts with the tip for negotiating calcified segments.
Contact Information
Corporate Office
- Rehov Hashoshanim 24
- Nesher 3684224
- Israel
Corporate Office
- Rehov Hashoshanim 24
- Nesher 3684224
- Israel
CardioSert (Novel Patent-Protected Technology) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CardioSert (Novel Patent-Protected Technology) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CardioSert (Novel Patent-Protected Technology) FAQs
-
Where is CardioSert (Novel Patent-Protected Technology) headquartered?
CardioSert (Novel Patent-Protected Technology) is headquartered in Nesher, Israel.
-
What industry is CardioSert (Novel Patent-Protected Technology) in?
CardioSert (Novel Patent-Protected Technology)’s primary industry is Other Healthcare Services.
-
Is CardioSert (Novel Patent-Protected Technology) a private or public company?
CardioSert (Novel Patent-Protected Technology) is a Private company.
-
What is the current valuation of CardioSert (Novel Patent-Protected Technology)?
The current valuation of CardioSert (Novel Patent-Protected Technology) is .
-
What is CardioSert (Novel Patent-Protected Technology)’s current revenue?
The current revenue for CardioSert (Novel Patent-Protected Technology) is .
-
Who are CardioSert (Novel Patent-Protected Technology)’s investors?
CardioSert has invested in CardioSert (Novel Patent-Protected Technology).
-
When was CardioSert (Novel Patent-Protected Technology) acquired?
CardioSert (Novel Patent-Protected Technology) was acquired on 08-Jan-2018.
-
Who acquired CardioSert (Novel Patent-Protected Technology)?
CardioSert (Novel Patent-Protected Technology) was acquired by Microbot Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
